<DOC>
	<DOCNO>NCT00906503</DOCNO>
	<brief_summary>RATIONALE : Imaging procedure , fludeoxyglucose F 18 ( FDG ) -PET/CT scan , do steroid therapy may help doctor assess patient 's response treatment help plan best treatment . PURPOSE : This phase I trial study fludeoxyglucose F 18 PET scan perform ultra short-term dexamethasone therapy see well measure change nodule patient lung nodule .</brief_summary>
	<brief_title>Fludeoxyglucose F 18-PET/CT Scans Patients Receiving Ultra Short-Term Dexamethasone For Lung Nodules</brief_title>
	<detailed_description>OBJECTIVES : - To determine whether ultra short-term steroid therapy ( 24-48 hour ) use increase accuracy fludeoxyglucose F 18 positron emission tomography/computed tomography ( FDG-PET/CT ) image categorize nodule patient pulmonary nodule . - To calculate overall sensitivity specificity nodule group , base FDG uptake , predict malignancy . - To gather effect-size estimate use improve quality large follow-up study . OUTLINE : Patients receive oral dexamethasone 40 , 28 , 16 , 4 hour image . Patients undergo fludeoxyglucose F 18 ( FDG ) -positron emission tomography/computed tomography ( PET/CT ) image baseline upon completion steroid therapy . After completion study therapy , patient follow 6 month .</detailed_description>
	<mesh_term>Multiple Pulmonary Nodules</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Presence ≥ 1 measurable pulmonary nodule ( 1.03.0 cm ) suggestive malignancy chronic inflammatory process positron emission tomography ( PET ) scan No lesion consistent malignancy inflammation accord history , PET finding , biopsy Baseline scan average time injection start scan within 5070 min Mean liver standardize uptake value ( SUV ) baseline scan normal No sign significant partial paravenous tracer administration image baseline scan No lung nodule ( ) suggestive lymphoma No lung lesion suggestive tuberculosis PATIENT CHARACTERISTICS : ECOG performance status 02 Blood glucose level ≤ 150 mg/100 mL Not pregnant nurse Fertile patient must use effective contraception Able tolerate PET/CT image No history diabetes No poorly control hypertension No prior malignancy basal cell squamous cell carcinoma skin , carcinoma situ , cancer participant disease free &lt; 3 year No active malignancy within past 5 year PRIOR CONCURRENT THERAPY : More 5 year since prior chemotherapy radiotherapy No concurrent steroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>pulmonary nodule</keyword>
</DOC>